107 related articles for article (PubMed ID: 3613331)
1. [Studies on bladder cancer using flow cytometry. II. Evaluation of prognosis and intravesical recurrence of bladder cancer based on flow cytometric DNA analysis].
Yoshikawa K; Tochigi T; Hoshi S; Orikasa S; Imai Y
Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):227-31. PubMed ID: 3613331
[No Abstract] [Full Text] [Related]
2. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
3. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
Xue J
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas.
Vindeløv LL; Christensen IJ; Engelholm SA; Guldhammer BH; Højgaard K; Sørensen BL; Wolf H
Cytometry; 1995 Jun; 22(2):93-102. PubMed ID: 7587754
[TBL] [Abstract][Full Text] [Related]
5. [Studies on bladder cancer by flow cytometry. I. Evaluation of the malignant potential of bladder cancer based on flow cytometric DNA analysis].
Yoshikawa K
Nihon Hinyokika Gakkai Zasshi; 1985 Apr; 76(4):483-90. PubMed ID: 4032909
[No Abstract] [Full Text] [Related]
6. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
Hosaka Y
Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
[TBL] [Abstract][Full Text] [Related]
7. Markers of prognosis in superficial bladder cancer.
Fradet Y
Semin Urol; 1992 Feb; 10(1):28-38. PubMed ID: 1565901
[No Abstract] [Full Text] [Related]
8. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
Bittard H; Lamy B; Billery C
J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
Sun X
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
[TBL] [Abstract][Full Text] [Related]
10. [Impulse cytophotometry and irrigation cytology in the diagnosis of bladder cancer].
Maier G; Blech M; Droese M; Ringert RH
Urologe A; 1990 Nov; 29(6):330-3. PubMed ID: 2291258
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
12. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
Maier G; Heissler HE; Blech M; Schröter W
Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
[TBL] [Abstract][Full Text] [Related]
13. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tissue disaggregation techniques of transitional cell bladder carcinomas for flow cytometry and chromosomal analysis.
Smeets AW; Pauwels RP; Beck HL; Feitz WF; Geraedts JP; Debruyne FM; Laarakkers L; Vooijs GP; Ramaekers FC
Cytometry; 1987 Jan; 8(1):14-9. PubMed ID: 3026756
[TBL] [Abstract][Full Text] [Related]
15. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder.
Norming U
Semin Urol; 1993 Aug; 11(3):154-63. PubMed ID: 8210836
[No Abstract] [Full Text] [Related]
17. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometry in diagnosis and treatment of bladder tumor].
Sun XJ; Song ZL; Wu DC
Zhonghua Wai Ke Za Zhi; 1994 Mar; 32(3):178-80. PubMed ID: 7842912
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of cytofluorometry in bladder tumors].
Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
[TBL] [Abstract][Full Text] [Related]
20. DNA-malignancy-grading of bladder tumor and its clinical significance.
Wang XZ; Ma YJ; Zheng JF; Qin HY
Chin Med J (Engl); 1992 Oct; 105(10):856-9. PubMed ID: 1291205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
